Pegaptanib and ranibizumab for neovascular age‐related macular degeneration: a systematic review
AUTOR(ES)
Takeda, A L
FONTE
BMJ Group
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1954893Documentos Relacionados
- Age-related macular degeneration: armed against ARMD
- Early stages of age-related macular degeneration: an immunofluorescence and electron microscopy study.
- Treatment of age-related macular degeneration
- Treatment of age-related macular degeneration
- Relation of the functional and structural fundus changes after submacular surgery for neovascular age-related macular degeneration.